News & Events
September 18, 2023
C-Path and EATRIS Join Forces with New Collaboration AgreementAMSTERDAM and TUCSON, Ariz., September 18, 2023 — Critical Path Institute (C-Path) and EATRIS (the European Research Infrastructure for Translational Medicine) are pleased to announce the signing of a collaboration agreement aimed at fostering actionable scientific and educational cooperation. This agreement marks a significant milestone in the pursuit of patient-centric innovation and the advancement of...
September 12, 2023
C-Path’s Rare Disease Clinical Outcome Assessment Consortium Launches Rare Disease COA ResourceThe Rare Disease COA Resource aims to simplify COA selection for use in rare disease drug development. TUCSON, Ariz., September 12, 2023 — The Rare Disease Clinical Outcome Assessment (COA) Consortium at Critical Path Institute (C-Path), a public-private partnership focused on optimizing COA selection during drug development for rare diseases, today announced the launch...
August 21, 2023
Postdoc Ruby Abrams Shares Professional Development Opportunities Provided by C-PathCritical Path Institute is dedicated to advancing careers in the medical development and regulatory science industries. We are happy to share the story of Postdoc Fellow, Quantitative Medicine, Ruby Abrams, who has enjoyed the professional development opportunities provided by C-Path. As a graduate of an applied math program, I did not have the background necessary...
August 17, 2023
C-Path to Host a Scientific Breakthrough Summit Oct. 26-27Addressing Unmet Regulatory Needs and Drug Development Opportunities through Collaborations in Type 1 Diabetes, Alpha-1 Antitrypsin Deficiency, Lysosomal Disorders, and Vulnerable Populations including Neonates TUCSON, Ariz., Aug. 17, 2023 – Critical Path Institute (C-Path), a leading nonprofit dedicated to accelerating drug development to advance better treatments for people worldwide, is pleased to announce its upcoming...
August 15, 2023
NORDs’ IAMRARE Registry Contributes Two New Datasets to C-Path’s RDCA-DAP, Boosting Rare Disease Research and Therapeutic AdvancementTUCSON, Ariz., August 15, 2023 — Critical Path Institute (C-Path) announced today that the National Organization for Rare Disorders (NORD), a founding partner of the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®), is integrating two new datasets to the platform. The FD/MAS Alliance and A Cure in Sight (ACIS) join five other IAMRARE® registries...